News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Kurve Therapeutics, Inc. Announces Development of New Intellectual Property to Target Drug Delivery in the Brain
Thursday, March 16, 2023Kurve Therapeutics announced it has filed for new intellectual property on its nosetobrain technology platform Kurves technology uses the neuronal pathway rather than the circulatory system which means the drug is delivered to the extracellular space...
PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
Wednesday, March 15, 2023PerkinElmer Inc today announced that it has successfully completed the previously announced divestiture of its Applied Food and Enterprise Services businesses to New Mountain Capital a growthoriented investment firm The resulting new highgrowth Life...
Mabwell Launched First in human Clinical Trial of Its Iron Homeostasis Regulating Macromolecular Drug 9MW3011
Wednesday, March 15, 2023Mabwell an innovative biopharmaceutical company with the layout of whole industry chain launched first in human clinical trial of its iron homeostasis regulating macromolecular drug MW The study CTR is a phase single center randomized doubleblindpla...
Pfizer Invests $43 Billion to Battle Cancer
Tuesday, March 14, 2023Pfizer Inc and Seagen Inc announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen a global biotechnology company that discovers develops and commercializes transformative cancer medicines for in cas...
VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan
Tuesday, March 14, 2023VectivBio Holding AG a clinicalstage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions and Asahi Kasei Pharma Corporation Asahi Kasei Pharma today announced the start of a Phase study investigating the...
SciSparc Receives Approval to conduct its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome
Friday, March 10, 2023SciSparc Ltd a specialty clinicalstage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system today announced the approval of the Israeli Ministry of Health to conduct its clinical trial title...
Servier Announces Partnership with QIAGEN to Develop New mIDH1 Companion Diagnostic Test to Support Servier's Onco-hematology Portfolio
Friday, March 10, 2023Servier a global pharmaceutical group today announced it has entered into a strategic partnership with QIAGEN a leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing t...
InvoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
Thursday, March 09, 2023InvoX Pharma Limited a UKbased whollyowned subsidiary of Sino Biopharmaceutical Limited with an advancing pipeline of innovative products today announces that it has successfully completed the acquisition of Fstar Therapeutics Inc a clinicalstage bio...
Amphastar Pharmaceuticals Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg
Thursday, March 09, 2023Amphastar Pharmaceuticals Inc announced that the US Food and Drug Administration FDA has granted approval of its New Drug Application NDA for naloxone hydrochloride nasal spray mg which is delivered utilizing the Companys proprietary nasal delivery d...
BioNxt Solutions Acquires Novel Precision Drug Coating and Delivery Technology
Wednesday, March 08, 2023BioNxt Solutions Inc is pleased to report that it has signed a definitive technology transfer and patent assignment agreement the Agreement to acquire certain technology and intellectual property assets and rights related to a novel solid oral drug d...
